Bibliography
Filters: Keyword is Health Status [Clear All Filters]
A scoping review of pediatric economic evaluation 1980-2014: do trends over time reflect changing priorities in evaluation methods and childhood disease? Expert Rev Pharmacoecon Outcomes Res. 2016;16(5):599-607. Abstract
Recommended patient-reported core set of symptoms to measure in adult cancer treatment trials. J Natl Cancer Inst. 2014;106(7). Abstract
A scoping review of pediatric economic evaluation 1980-2014: do trends over time reflect changing priorities in evaluation methods and childhood disease? Expert Rev Pharmacoecon Outcomes Res. 2016;16(5):599-607. Abstract
Recommended patient-reported core set of symptoms to measure in adult cancer treatment trials. J Natl Cancer Inst. 2014;106(7). Abstract
Recommended patient-reported core set of symptoms to measure in adult cancer treatment trials. J Natl Cancer Inst. 2014;106(7). Abstract
A scoping review of pediatric economic evaluation 1980-2014: do trends over time reflect changing priorities in evaluation methods and childhood disease? Expert Rev Pharmacoecon Outcomes Res. 2016;16(5):599-607. Abstract
A scoping review of pediatric economic evaluation 1980-2014: do trends over time reflect changing priorities in evaluation methods and childhood disease? Expert Rev Pharmacoecon Outcomes Res. 2016;16(5):599-607. Abstract
Recommended patient-reported core set of symptoms to measure in adult cancer treatment trials. J Natl Cancer Inst. 2014;106(7). Abstract
Recommended patient-reported core set of symptoms to measure in adult cancer treatment trials. J Natl Cancer Inst. 2014;106(7). Abstract
A scoping review of pediatric economic evaluation 1980-2014: do trends over time reflect changing priorities in evaluation methods and childhood disease? Expert Rev Pharmacoecon Outcomes Res. 2016;16(5):599-607. Abstract
A scoping review of pediatric economic evaluation 1980-2014: do trends over time reflect changing priorities in evaluation methods and childhood disease? Expert Rev Pharmacoecon Outcomes Res. 2016;16(5):599-607. Abstract
A scoping review of pediatric economic evaluation 1980-2014: do trends over time reflect changing priorities in evaluation methods and childhood disease? Expert Rev Pharmacoecon Outcomes Res. 2016;16(5):599-607. Abstract
Health technology assessment in France. Int J Technol Assess Health Care. 2000;16(2):400-11. Abstract
Health technology assessment in France. Int J Technol Assess Health Care. 2000;16(2):400-11. Abstract
Recommended patient-reported core set of symptoms to measure in adult cancer treatment trials. J Natl Cancer Inst. 2014;106(7). Abstract
Recommended patient-reported core set of symptoms to measure in adult cancer treatment trials. J Natl Cancer Inst. 2014;106(7). Abstract
Recommended patient-reported core set of symptoms to measure in adult cancer treatment trials. J Natl Cancer Inst. 2014;106(7). Abstract
A scoping review of pediatric economic evaluation 1980-2014: do trends over time reflect changing priorities in evaluation methods and childhood disease? Expert Rev Pharmacoecon Outcomes Res. 2016;16(5):599-607. Abstract
Recommended patient-reported core set of symptoms to measure in adult cancer treatment trials. J Natl Cancer Inst. 2014;106(7). Abstract